Bender Matthew T, Ward Austin N, Iocono Joseph A, Saha Sibu P
College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Am Surg. 2015 Sep;81(9):849-53.
Empyema is a morbid complication of pneumonia in children, whose gold standard of surgical treatment technique remains undefined. Historically, treatment consisted of open thoracotomy with decortication. We evaluate the effectiveness and safety of video-assisted thoracoscopic surgery (VATS) as a surgical treatment in for empyema thoracis in a pediatric population at a single institution from 2005 to 2013. After receiving Institutional Review Board approval, we performed a retrospective chart review of children surgically treated for empyema as a complication of pneumonia from 2005 to 2013. Charts were reviewed for the type of procedure performed (VATS or open thoracotomy), comorbid conditions, preoperative status, operative outcomes, and postoperative status. A total of 112 pediatric patients were treated surgically for empyema. Surgical treatment consisted of VATS in all cases; no open thoracotomy procedures were performed. The success rate of VATS in our study was 96.4 per cent. Mean total length of stay was found to be 8.8 days, whereas postoperative length of stay was 6.3 days. Mean postoperative chest tube duration was 3.4 days. Perioperative complication rate was 11.6 per cent, with respiratory failure being the most common complication. The data from our study demonstrate that the exclusive use of VATS in children for the surgical management of all stages of empyema was safe and produced results with high efficacy. We consider VATS to be the new gold standard for surgical drainage of empyema.
脓胸是儿童肺炎的一种严重并发症,其外科治疗技术的金标准尚未明确。历史上,治疗方法包括开胸剥脱术。我们评估了2005年至2013年期间在单一机构中,电视辅助胸腔镜手术(VATS)作为小儿脓胸外科治疗方法的有效性和安全性。在获得机构审查委员会批准后,我们对2005年至2013年期间因肺炎并发症而接受脓胸手术治疗的儿童进行了回顾性病历审查。审查了所进行的手术类型(VATS或开胸手术)、合并症、术前状况、手术结果和术后状况。共有112例小儿患者接受了脓胸手术治疗。所有病例的手术治疗均采用VATS;未进行开胸手术。我们研究中VATS的成功率为96.4%。平均总住院时间为8.8天,而术后住院时间为6.3天。术后平均胸管留置时间为3.4天。围手术期并发症发生率为11.6%,呼吸衰竭是最常见的并发症。我们研究的数据表明,在儿童中仅使用VATS进行脓胸各阶段的外科治疗是安全的,且疗效显著。我们认为VATS是脓胸外科引流的新金标准。